期刊文献+

索拉非尼所致腹泻中医临床用药规律分析 被引量:4

Medication rule of traditional Chinese medicine on diarrhea caused by sorafenib
下载PDF
导出
摘要 目的:基于数据挖掘探讨原发性肝癌患者使用索拉非尼所致腹泻的中医临床辩证及用药规律,进而探讨其用药特点,用于指导临床。方法:收集中国人民解放军第五医学中心(原解放军第302医院)住院原发性肝癌患者使用索拉非尼所致腹泻病例资料,建立临床用药的数据库,对数据进行频数分析、关联规则等分析。结果:对159例患者病例资料分析,其主证型从高到低依次为:湿热内蕴证、脾虚湿盛证、肝郁脾虚证、肝郁脾虚兼肝血瘀阻证、脾肾阳虚证,其中湿热内蕴证临床总有效率最高。药物使用频率居于前12位的药物分别为:半夏、黄芩、黄连、生地、香附、甘草、党参、薏苡仁、黄芪、干姜、川芎、吴茱萸,以“清热解毒、健脾利湿、温阳健脾”药物为主。结论:原发性肝癌患者使用索拉非尼所致腹泻,最常见的临床证型为湿热内蕴证,清热、利湿、健脾、理气、化瘀、温阳”为中医治疗索拉非尼所致腹泻的主要治则。 Objective:To explore the clinical dialectics and medication regularity of TCM in Diarrhea caused by sorafenib,which may guide the treatment.Methods:The clinical research part,collecting cases material from the fifth medical center of the Chinese people's liberation army(former PLA 302 hospital),established the clinical drugs database,used frequency analysis and association rules to research the medication characteristics.Results:Analyzing the case data of 159 patients in hospital,the TCM syndrome type proportional from high to low in turn is Damp-heat syndrome,damp-heat deficiency of spleen syndrome,liver-stagnation of spleen deficiency syndrome,liver-stagnation of spleen deficiency with liver-blood stasis syndrome,spleen-kidney Yang deficiency syndrome.The therapy effect of Damp-heat syndrome has been considered with the highest treatment efficacy.The first 12 agent medicines were pinellia ternata,scutellaria baicalensis,rhizoma coptidis,radix cyperi,liquorice,codonopsis pilosula,coix seed,astragalus membranaceus,dried ginger,ligusticum chuanxiong,evodia officinalis.Conclusion:The most common clinical syndrome type is Damp-heat syndrome."clearing heat,benefiting dampness,invigorating spleen,regulating qi,removing blood stasis and warming Yang"are the main principles of traditional Chinese medicine in treating Diarrhea caused by sorafenib.
作者 张帆 伍玉南 景婧 孙克伟 ZHANAG Fan;WU Yu-nan;JING Jing;SUN Ke-wei(The Third People's Hospital of Shenzhen,Guangdong,Shenzhen,518112,China)
出处 《中西医结合肝病杂志》 CAS 2021年第5期402-404,共3页 Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
基金 国家自然科学基金青年科学基金项目(No.81503556) 国家自然科学基金(No.81704068) 数字中医药湖南省高等学校2011协同创新中心中医临床数字化与应用研究平台-肝病中心协同创新团队(No.统计99-15) 湖南省研究生科研创新项目(No.CX2018B472)。
关键词 索拉非尼 腹泻 数据挖掘 中医药 辨证用药规律 sorafenib diarrhea data mining traditional Chinese medicine law of dialectical drug use
  • 相关文献

参考文献6

二级参考文献73

  • 1吴孟航,刘继彦,赵煜,彭星辰,何建萍,魏蒙,谭本旭,李虹,汪秀云,许峰,毕锋.索拉非尼治疗晚期肾细胞癌不良反应的观察和处理[J].华西医学,2008,23(6):1429-1431. 被引量:3
  • 2中国腹泻病诊断治疗方案[J].临床儿科杂志,1994,12(3):148-151. 被引量:459
  • 3王洪琦,崔娜娟,胡玲,李建国,胡晨霞,成晓燕.清热解毒中药对荷瘤鼠恶性肿瘤HSP70免疫作用影响的实验研究[J].新中医,2006,38(2):91-93. 被引量:4
  • 4刘鲁明.辨证分型治疗肝硬化腹水172例疗效观察[J].四川中医,2007,25(7):59-60. 被引量:34
  • 5Hutson TE,Bellmunt J,Porta C,et al.Long-term safety of sorafenib in advanced renal cell carcinoma: follow-up of patients from phase Ill TARGET[J].Eur J Cancer,2010,46(13):2432-2440.
  • 6Escudier B,Eisen T,Stadler WM,et al.Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial[J].J Clin Oncol,2009,27(20):3312-3318.
  • 7Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden ofcancer in 2008: GLOBOCAN 2008[j]. IntJ Cancer, 2010, 127(12):2893-2917.
  • 8Tanaka M, Katayama F, Kato H,et al.Hepatitis B and C virus infectionand hepatocellular carcinoma in China: a review of epidemiology andcontrol measures[J].J Epidemiol, 2011, 21(6):401-416.
  • 9El-Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma inthe United States: where are we. Where do we go.[j]. Hepatology,2014,60(5):1767-1775.
  • 10Trepo C, Chan HL, Lok A. Hepatitis B virus infection[j]. Lancet,2014,384(9959): 2053-2063.

共引文献26

同被引文献76

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部